Okada Ayako, Shoda Morio, Tabata Hiroaki, Kobayashi Hideki, Shoin Wataru, Okano Takahiro, Yoshie Koji, Kato Ken, Motoki Hirohiko, Kuwahara Koichiro
Department of Cardiovascular Medicine, Shinshu University School of Medicine, Nagano, Japan.
Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.
J Cardiol Cases. 2020 Oct 3;23(1):35-37. doi: 10.1016/j.jccase.2020.09.005. eCollection 2021 Jan.
An 80-year-old man with a history of dilated hypertrophic cardiomyopathy received a dual-chamber pacemaker for sick sinus syndrome and atrioventricular block in February 2010. On May 30, 2019, he developed pocket erosion, with streaks of pus exuding from the pocket. The pacemaker generator was removed, although both capping leads were left buried under the skin, and a leadless pacemaker was implanted into the right ventricular (RV) apex the next day. Blood and pus cultures on July 15, 2019 indicated methicillin-resistant (MRSA). The patient was transferred to our hospital for simultaneous removal of both devices in August 2019. The RV lead and right atrial lead were extracted using a laser sheath and a mechanical sheath. A 23 Fr MICRA® sheath was inserted from the right femoral vein to accommodate an 8.5 Fr Agillis sheath. An Osypka LASSO snare catheter was advanced through the sheath to catch the distal aspect of the MICRA® body. Finally, the MICRA® device was completely removed through the sheath. Culture results for the lead tip and MICRA® were both MRSA positive. This is the first report of late-phase simultaneous infection of abandoned leads and implanted leadless cardiac pacemaker extraction. < Leadless pacemakers are becoming increasingly popular in high-risk patients due to no lead-associated complications. As a result of the incomplete removal, the remaining leads caused a drug-refractory blood stream infection, which secondarily infected the MICRA® device. Thus, an insufficiently treated pocket infection resulted in persistent methicillin-resistant bacteremia in this case.>.
一名患有扩张型肥厚性心肌病的80岁男性于2010年2月因病态窦房结综合征和房室传导阻滞接受了双腔起搏器植入。2019年5月30日,他出现了起搏器囊袋糜烂,有脓液从囊袋中渗出。起搏器发生器被取出,尽管两根封盖导线仍留在皮下,次日在右心室(RV)心尖植入了无导线起搏器。2019年7月15日的血液和脓液培养显示为耐甲氧西林(MRSA)。患者于2019年8月被转至我院同时取出这两种装置。使用激光鞘和机械鞘取出RV导线和右心房导线。从右股静脉插入一个23 Fr的MICRA®鞘以容纳一个8.5 Fr的Agillis鞘。一根Osypka LASSO圈套导管通过鞘推进以抓住MICRA®主体的远端。最后,MICRA®装置通过鞘被完全取出。导线尖端和MICRA®的培养结果均为MRSA阳性。这是关于废弃导线晚期同时感染及植入无导线心脏起搏器取出的首例报告。<由于无导线相关并发症,无导线起搏器在高危患者中越来越受欢迎。由于取出不完全,残留的导线导致了药物难治性血流感染,继而感染了MICRA®装置。因此,在本病例中,囊袋感染治疗不充分导致了持续的耐甲氧西林菌血症。>